Financials
Financial year 2025
PHARMACIE DU SOUVERAIN from Oudergem, company number BE0885751837, closed financial year 2025 with a result of € 84,228 after tax. For that financial year PHARMACIE DU SOUVERAIN recorded a gross margin of € 341,795 and equity of € 253,569. Compared with financial year 2024, the result moved from € 21,349 to € 84,228. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 19, 2026.
€ 253,569
▲ 50% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 84,228
▲ 295% vs 2024
Profit after tax over the fiscal year.
€ 171,700
▼ 5% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 128,569.
People and assets in 2025
3.2
▼ 0.2 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 230,023
▼ 8% vs 2024
€ 71,900 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 8,426
▲ 32% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 137,925
▼ 27% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 56,428
▲ 13% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 315,456 | € 324,846 | € 301,208 | € 341,795 | ▲ 13% |
| Profit after taxes | € 63,658 | € 63,427 | € 21,349 | € 84,228 | ▲ 295% |
| Equity | € 84,564 | € 147,991 | € 169,341 | € 253,569 | ▲ 50% |
| Total debts | € 280,576 | € 220,136 | € 271,211 | € 194,705 | ▼ 28% |
| Cash | € 95,101 | € 124,568 | € 181,634 | € 171,700 | ▼ 5% |
| Retained profit | € -40,436 | € 22,991 | € 44,341 | € 128,569 | ▲ 190% |
| Bank debt | € 45,412 | € 15,344 | € 0 | € 0 | |
| Balance sheet total | € 366,780 | € 369,856 | € 442,362 | € 450,280 | ▲ 2% |
| Employees (FTE) | 3.3 | 3.1 | 3.4 | 3.2 | ▼ 0.2 |
Key figures of PHARMACIE DU SOUVERAIN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PHARMACIE DU SOUVERAIN?
What happened at PHARMACIE DU SOUVERAIN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- ALCYON Belux stepped down as director. NBB
- Emmanuel BATAILLE stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 84,228 (▲ 295% vs 2024). Source: NBB ↗
- ALCYON Belux became a director. NBB
- Emmanuel BATAILLE became a director. NBB
- Start of the company according to the CBE. KBO
- New establishment in Oudergem. KBO
In short
From € 63,658 profit in 2022 to € 84,228 profit in 2025.
Paid € 83,421 in corporate taxes since 2022.
Best year ever: 2025, with € 84,228 profit.
On average € 106,800 of value added per employee in 2025.
A new publication or filing at PHARMACIE DU SOUVERAIN? We notify you, reason included.
Follow PHARMACIE DU SOUVERAINDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of ALCYON BELUX DISTRIBUTION VETERINAIRE comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
PHARMACIE DU SOUVERAINThe shares are held by ALCYON BELUX DISTRIBUTION VETERINAIRE (99.9%).
Directors
According to the 2025 annual accounts
since 2022 · until 2028
Emmanuel BATAILLE
Director
since 2022 · until 2028
Shareholders
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Vorstlaan 264
1160 Oudergem
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0885.751.837
- VAT number
- BE 0885.751.837
- Registered office
- Vorstlaan 264, 1160 Oudergem
- Names & denominations
- PHARMACIE DU SOUVERAIN
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 18 December 2006
- Peppol
- Active · Active since 8 Jan 2026
- Activities · NACE
Detailhandel in farmaceutische producten
Activiteiten van holdings
Managementactiviteiten van holdings
Holdings
Activiteiten van hoofdkantoren
Coördinatiecentra